Common Contracts
31 similar Collaborative Research Agreement contracts by Abgenix Inc, Diversa Corp, Xenogen Corp, others
AND ---Collaborative Research Agreement • September 20th, 2005 • Kyto Biopharma Inc • Pharmaceutical preparations
EXHIBIT 10.7 Collaborative Research Agreement This agreement dated as of November 1, 2001 between Pfizer Inc, a Delaware corporation, having a principal place of business at 235 E 42nd Street, New York, New York 10017 and its Affiliates ("Pfizer") and...Collaborative Research Agreement • November 17th, 2003 • Exten Industries Inc • Surgical & medical instruments & apparatus • New York
RECITALSCollaborative Research Agreement • March 31st, 2003 • Dor Biopharma Inc • Pharmaceutical preparations
AND ---Collaborative Research Agreement • August 22nd, 2002 • B Twelve Inc • Pharmaceutical preparations
UBC LOGO]Collaborative Research Agreement • January 24th, 2002 • DBS Holdings Inc • Blank checks
EXHIBIT 10.4 Agreement dated for reference the 23rd day of May, 2001. COLLABORATIVE RESEARCH AGREEMENT BETWEEN: MIVI TECHNOLOGIES INC. , a company incorporated under the laws of Yukon Territory and having its offices at Unit 1, 8765 Ash Street, in the...Collaborative Research Agreement • December 3rd, 2001 • DBS Holdings Inc • Blank checks • British Columbia
REDACTED FOR CONFIDENTIALITY CONFIDENTIAL TREATMENT REQUESTEDCollaborative Research Agreement • April 9th, 2001 • Diadexus Inc • Services-commercial physical & biological research • Pennsylvania
RECITALS --------Collaborative Research Agreement • January 26th, 2001 • Xenogen Corp • Services-commercial physical & biological research • New Jersey
RECITALS --------Collaborative Research Agreement • January 16th, 2001 • Xenogen Corp • Services-commercial physical & biological research • New Jersey
RECITALS --------Collaborative Research Agreement • January 3rd, 2001 • Xenogen Corp • Services-commercial physical & biological research • New Jersey
1 EXHIBIT 99.2 COLLABORATIVE RESEARCH AGREEMENT This COLLABORATIVE RESEARCH AGREEMENT (The "Agreement") is entered into as of the Effective Date by and between PFIZER INC, a Delaware corporation, having an office at 235 East 42nd Street, New York, NY...Collaborative Research Agreement • September 7th, 2000 • Atrix Laboratories Inc • Pharmaceutical preparations • New York
AGREEMENTCollaborative Research Agreement • June 20th, 2000 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
Amendment to the Collaborative Research Agreement This Agreement (the "2000 Amendment") is entered into as of March 1, 2000 by and between Pfizer Inc. ("Pfizer"), a Delaware corporation, having an office at 235 East 42nd Street, New York, New York...Collaborative Research Agreement • June 19th, 2000 • Microcide Pharmaceuticals Inc • Pharmaceutical preparations
ARTICLE TITLE PAGE NUMBER ----------------------------------------------------- ---------------------------------------------- 1 DEFINITIONS 1 ---------------- ------------------------------------------------------------------------------- ---- 2 R&D...Collaborative Research Agreement • February 11th, 2000 • Diversa Corp • Services-commercial physical & biological research • Delaware
ARTICLE TITLE PAGE NUMBER ----------------------------------------------------- ---------------------------------------------- 1 DEFINITIONS 1 ---------------- ------------------------------------------------------------------------------- ---- 2 R&D...Collaborative Research Agreement • February 9th, 2000 • Diversa Corp • Services-commercial physical & biological research • Delaware
ARTICLE TITLE PAGE NUMBER ----------------------------------------------------- ---------------------------------------------- 1 DEFINITIONS 1 ---------------- ------------------------------------------------------------------------------- ---- 2 R&D...Collaborative Research Agreement • December 21st, 1999 • Diversa Corp • Services-commercial physical & biological research
1 Exhibit 10.29B AMENDMENT NO. 3 TO COLLABORATIVE RESEARCH AGREEMENT This Amendment No. 3 to the Collaborative Research Agreement (the "Amendment No. 3"), effective as of February 12, 1999 (the "Amendment No. 3 Effective Date"), is made by and between...Collaborative Research Agreement • February 25th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances)
AMENDMENT NO. 2 TO COLLABORATIVE RESEARCH AGREEMENTCollaborative Research Agreement • February 4th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances)
1 EXHIBIT 10.27B [PFIZER LETTERHEAD] GEORGE M. MILNE, JR., PH.D. October 22, 1998 President Mr. Scott Greer President Abgenix, Inc. 7601 Dumbarton Circle Fremont, CA 94555 Dear Mr. Greer, Further to our recent discussions, Pfizer Inc ("Pfizer") and...Collaborative Research Agreement • January 15th, 1999 • Abgenix Inc • Biological products, (no disgnostic substances)
1 Exhibit 10.83 [SEQUANA THERAPEUTICS LETTERHEAD] January 9, 1998 Claus-Jorg Ruetsch VP of International Legal Affairs German Offices Sandhofer Strasse 176 D-68305 Mannheim Germany Dear Dr. Ruetsch, COLLABORATIVE RESEARCH AGREEMENT BETWEEN SEQUANA...Collaborative Research Agreement • May 15th, 1998 • Axys Pharmecueticals Inc • Pharmaceutical preparations
1 EXHIBIT 10.84 AMENDMENT NO. 2 TO COLLABORATIVE RESEARCH AGREEMENT BETWEEN SEQUANA THERAPEUTICS, INC. AND CORANGE INTERNATIONAL LTD. DATED 30TH JUNE, 1995 This Amendment No. 2 (the "Amendment") to the Collaborative Research Agreement entered into as...Collaborative Research Agreement • May 15th, 1998 • Axys Pharmecueticals Inc • Pharmaceutical preparations
COLLABORATIVE RESEARCH AGREEMENT -------------------------------- This agreement ("AGREEMENT") is made as of August 1, 1997 ("EFFECTIVE DATE") by and between BOSTON MEDICAL CENTER CORPORATION (hereinafter referred to as "BMCC"), a Massachusetts...Collaborative Research Agreement • April 15th, 1998 • Oxigene Inc • Biological products, (no disgnostic substances) • Massachusetts
AMENDMENT NO. 1 TO COLLABORATIVE RESEARCH AGREEMENT BETWEEN GILEAD SCIENCES, INC. AND GLAXO WELLCOME INC. DATED DECEMBER 22, 1997Collaborative Research Agreement • March 31st, 1998 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
EXHIBIT 10.35 COLLABORATIVE RESEARCH AGREEMENT This agreement made as of the 7th day of May, 1997 ("Effective Date"), between Magna-Lab Inc., a New York corporation, having a principal place of business at 250Z Executive Drive, Edgewood, New York...Collaborative Research Agreement • October 24th, 1997 • Magna Lab Inc • Electromedical & electrotherapeutic apparatus • New York
EXHIBIT 10.18 COLLABORATIVE RESEARCH AGREEMENT This COLLABORATIVE RESEARCH AGREEMENT is entered into as of May 31, 1996 by and between PFIZER INC., a Delaware corporation, having an office at 235 East 42nd Street, New York, New York 10017 and its...Collaborative Research Agreement • July 31st, 1997 • Megabios Corp • New York
1 EXHIBIT 10.40 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omissions. COLLABORATIVE RESEARCH AGREEMENT This COLLABORATIVE RESEARCH AGREEMENT is entered into as of January 1,...Collaborative Research Agreement • March 31st, 1997 • Millennium Pharmaceuticals Inc • Pharmaceutical preparations • New York
AGREEMENTCollaborative Research Agreement • December 30th, 1996 • Oncogene Science Inc • In vitro & in vivo diagnostic substances • New York
1 EXHIBIT 10.8 CHEMGENICS PHARMACEUTICALS INC. HAS OMITTED FROM THIS PART OF EXHIBIT 10.8 PORTIONS OF THE AGREEMENT FOR WHICH CHEMGENICS PHARMACEUTICALS INC. HAS REQUESTED CONFIDENTIAL TREATMENT FROM THE SECURITIES AND EXCHANGE COMMISSION. THE...Collaborative Research Agreement • December 18th, 1996 • Chemgenics Pharmaceuticals Inc • New York
EXHIBIT 10.7 COLLABORATIVE RESEARCH AGREEMENT * THIS COLLABORATIVE RESEARCH AGREEMENT is made as of the 23rd day of July 1996, between BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., a Delaware corporation having offices at 900 Ridgebury Road, Ridgefield,...Collaborative Research Agreement • November 14th, 1996 • Viropharma Inc • Pharmaceutical preparations • Pennsylvania
by and amongCollaborative Research Agreement • November 1st, 1996 • Codon Pharmaceuticals Inc • Maryland
2 1. DEFINITIONS Whenever used in this Agreement, the terms defined in this Section 1 shall have the meanings specified. 1.1 "AFFILIATE" means any corporation or other legal entity owning, directly or indirectly, fifty percent (50%) or more of the...Collaborative Research Agreement • October 22nd, 1996 • Gensia Inc • Pharmaceutical preparations • New York
